← Leaderboards
Shusheng Wang
Ut Southwestern Medical Center
$6,641,450
Attributed
$7,272,502
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,272,502 · 5
By mechanism
R01$7,245,502 · 4
R13$27,000 · 1
Top collaborators
- James T Handa2 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Kristin Marie Myers$4,778,928
- Rafael Ufret-Vincenty$4,610,296
- Joseph A. Hill$28,732,318
- William L Kraus$26,921,621
- Yasin Yousef Dhaher$7,452,372
Others in their field
Top investigators on “Age Related Macular Degeneration”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Rohit Varma · University Of Southern California$50,124,787
- Maureen G Maguire · University Of Pennsylvania$38,506,792
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Krzysztof Palczewski · University Of California-Irvine$27,513,979
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
Age Related Macular DegenerationPathogenesisPathway InteractionsResponseTechnologyAngiogenesisVascular Endothelial Growth FactorsEndothelial CellsOcular AngiogenesisRegulationNeovascularizationLasersSmall MoleculeMicrornasProto-Oncogene Proteins C-AktChoroidal NeovascularizationCellsMesenchymalSignal TransductionTherapeutic TargetBaseCombatComplexPlay
Grant awards (19)
Does age/stress-induced mitochondrial dysfunction induce variations in RPE phenotype in AMD?$651,702
R01 · FY2025 · EY · contact PI
Mechanistic study and therapeutic development for subretinal fibrosis$435,204
R01 · FY2025 · EY · contact PI
Does age/stress-induced mitochondrial dysfunction induce variations in RPE phenotype in AMD?$610,403
R01 · FY2024 · EY · contact PI
Mechanistic study and therapeutic development for subretinal fibrosis$435,204
R01 · FY2024 · EY · contact PI
Mechanistic study and therapeutic development for subretinal fibrosis$388,188
R01 · FY2023 · EY · contact PI
Regulation of Ocular Angiogenesis by microRNAs$368,600
R01 · FY2021 · EY · contact PI
Role of long noncoding RNAs in human ocular angiogenesis$376,250
R01 · FY2020 · EY · contact PI
Regulation of Ocular Angiogenesis by microRNAs$342,000
R01 · FY2020 · EY · contact PI
Role of long noncoding RNAs in human ocular angiogenesis$376,250
R01 · FY2019 · EY · contact PI
Regulation of Ocular Angiogenesis by microRNAs$341,063
R01 · FY2019 · EY · contact PI
XIV Biennial Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT)$27,000
R13 · FY2019 · EY · contact PI
Role of long noncoding RNAs in human ocular angiogenesis$376,250
R01 · FY2018 · EY · contact PI
Role of long noncoding RNAs in human ocular angiogenesis$376,250
R01 · FY2017 · EY · contact PI
Role of long noncoding RNAs in human ocular angiogenesis$376,250
R01 · FY2016 · EY · contact PI
Regulation of ocular angiogenesis by microRNAs$368,725
R01 · FY2015 · EY · contact PI
Regulation of ocular angiogenesis by microRNAs$368,725
R01 · FY2014 · EY · contact PI
Regulation of ocular angiogenesis by microRNAs$357,438
R01 · FY2013 · EY · contact PI
Regulation of ocular angiogenesis by microRNAs$357,749
R01 · FY2012 · EY · contact PI
Regulation of ocular angiogenesis by microRNAs$339,251
R01 · FY2011 · EY · contact PI